ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Boan Biotech Publishes Research Results for CEA/CD3 Bispecific Antibody in Antibody Therapeutics
June 25, 2021Luye Pharma Group's subsidiary Boan Biotech recently published research results for its innovative in-house bispecific antibody BA1202 (CEA/CD3 bispecific T-cell engager) in Antibody Therapeutics. -
Lilly and Merus partner to develop T-Cell re-directing antibody therapies
January 21, 2021Research and development group of Eli Lilly and Company, Loxo Oncology at Lilly, and clinical-stage oncology company Merus have announced a research collaboration and exclusive license agreement to develop T-Cell re-directing bispecific antibodies.
Pharma Sources Insight January 2025
